| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...872662D |
| P356 | DOI | 10.1371/JOURNAL.PONE.0072662 |
| P932 | PMC publication ID | 3756000 |
| P698 | PubMed publication ID | 24015269 |
| P5875 | ResearchGate publication ID | 256470826 |
| P2093 | author name string | Min Deng | |
| Zhi-min He | |||
| Xiao-min Lu | |||
| Ji-fang Liu | |||
| Hai-lin Tang | |||
| Mei-yuan Liu | |||
| Xi-hong Lu | |||
| Yi-xue Gu | |||
| P2860 | cites work | MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein | Q24601263 |
| miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis | Q24613599 | ||
| The role of miR-26 in tumors and normal tissues (Review) | Q24629056 | ||
| Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL) | Q24629558 | ||
| miRiad roles for the miR-17-92 cluster in development and disease | Q24646970 | ||
| MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
| Genetic dissection of the miR-17~92 cluster of microRNAs in Myc-induced B-cell lymphomas | Q24652219 | ||
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
| MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin | Q28263940 | ||
| Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival | Q28264400 | ||
| Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor | Q28264817 | ||
| MiR-26a inhibits cell growth and tumorigenesis of nasopharyngeal carcinoma through repression of EZH2 | Q28302211 | ||
| MicroRNA in cancer prognosis | Q28304380 | ||
| Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma | Q28304953 | ||
| Specificity of microRNA target selection in translational repression | Q28776123 | ||
| Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms | Q30482634 | ||
| MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor | Q33543185 | ||
| Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis | Q34089030 | ||
| MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. | Q34120830 | ||
| Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | Q34159409 | ||
| Trastuzumab produces therapeutic actions by upregulating miR-26a and miR-30b in breast cancer cells | Q34181700 | ||
| The duality of oncomiR addiction in the maintenance and treatment of cancer | Q34278112 | ||
| Enhancer of Zeste homolog 2 (EZH2) is overexpressed in recurrent nasopharyngeal carcinoma and is regulated by miR-26a, miR-101, and miR-98. | Q34561758 | ||
| MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis | Q34835189 | ||
| Survival prediction of gastric cancer by a seven-microRNA signature | Q35015473 | ||
| MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia | Q36437006 | ||
| MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? | Q38053397 | ||
| MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma | Q39196206 | ||
| Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells | Q39289136 | ||
| miR-216b suppresses tumor growth and invasion by targeting KRAS in nasopharyngeal carcinoma | Q39482095 | ||
| Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas | Q40322109 | ||
| MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma | Q42723195 | ||
| miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma | Q44424639 | ||
| Meta-analysis of microRNA expression in lung cancer | Q45083188 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e72662 | |
| P577 | publication date | 2013-08-28 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | miR-26a suppresses tumor growth and metastasis by targeting FGF9 in gastric cancer | |
| P478 | volume | 8 |
| Q98176753 | CircularRNA-9119 protects hepatocellular carcinoma cells from apoptosis by intercepting miR-26a/JAK1/STAT3 signaling |
| Q35968528 | Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer |
| Q92286877 | Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer |
| Q92617953 | Diagnostic value of a microRNA signature panel in exosomes for patients with hepatocellular carcinoma |
| Q39346497 | Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role |
| Q35203269 | Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma |
| Q54146288 | Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer. |
| Q35618147 | FGF9 from cancer-associated fibroblasts is a possible mediator of invasion and anti-apoptosis of gastric cancer cells |
| Q89909161 | FGF9 promotes cisplatin resistance in colorectal cancer via regulation of Wnt/β-catenin signaling pathway |
| Q58713781 | FGF9/FGFR2 increase cell proliferation by activating ERK1/2, Rb/E2F1, and cell cycle pathways in mouse Leydig tumor cells |
| Q46317673 | Förster resonance energy transfer to impart signal-on and -off capabilities in a single microRNA biosensor |
| Q36733776 | Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia |
| Q30878074 | Identifying cancer-related microRNAs based on gene expression data |
| Q38572855 | Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review |
| Q49236880 | Integrated MicroRNA-mRNA Analysis Reveals miR-204 Inhibits Cell Proliferation in Gastric Cancer by Targeting CKS1B, CXCL1 and GPRC5A. |
| Q64071558 | LncRNA SNHG6 promotes the migration, invasion, and epithelial-mesenchymal transition of colorectal cancer cells by miR-26a/EZH2 axis |
| Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
| Q37046835 | MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2. |
| Q38828580 | MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2 |
| Q58695821 | MicroRNA Expression Profiles in Gastric Carcinogenesis |
| Q35678702 | MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways |
| Q39012739 | MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer |
| Q36686905 | MicroRNA-203 suppresses gastric cancer growth by targeting PIBF1/Akt signaling |
| Q49790324 | MicroRNA-26a and Tumor |
| Q41856145 | MicroRNA-26a inhibits osteosarcoma cell proliferation by targeting IGF-1. |
| Q33886196 | MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene |
| Q54094778 | MicroRNA-26a regulates ANXA1, rather than DAL-1, in the development of lung cancer. |
| Q38714023 | MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines |
| Q92383032 | MicroRNA-431 serves as a tumor inhibitor in breast cancer through targeting FGF9 |
| Q34168445 | MicroRNAs as potential biomarkers for gastric cancer |
| Q48103728 | Plasma microRNA-based signatures to predict 3-year postoperative recurrence risk for stage II and III gastric cancer |
| Q39237748 | Prognostic role of microRNAs in human gastrointestinal cancer: A systematic review and meta-analysis |
| Q41548169 | Prognostic value of microRNAs in gastric cancer: a meta-analysis |
| Q26785548 | Recent advances in the molecular diagnostics of gastric cancer |
| Q38191102 | Regulation of microRNAs in cancer metastasis. |
| Q98386355 | Small RNA profiles of HTLV-1 asymptomatic carriers with monoclonal and polyclonal rearrangement of the T-cell antigen receptor γ-chain using massively parallel sequencing: A pilot study |
| Q34467171 | The Fibroblast Growth Factor signaling pathway |
| Q37392801 | The anti-apoptotic and prognostic value of fibroblast growth factor 9 in gastric cancer |
| Q26742058 | The expanding regulatory universe of p53 in gastrointestinal cancer |
| Q27026837 | The functional sites of miRNAs and lncRNAs in gastric carcinogenesis |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q50147073 | Three-Dimensional Cellular Arrangement in Epithelial Ovarian Cancer Cell Lines TOV-21G and SKOV-3 is Associated with Apoptosis-Related miRNA Expression Modulation. |
| Q57110556 | Translational models of prostate cancer bone metastasis |
| Q37288437 | miR-101 inhibits glioma cell invasion via the downregulation of COX-2. |
| Q55293830 | miR-1236-3p inhibits invasion and metastasis in gastric cancer by targeting MTA2. |
| Q55711392 | miR-124-3p acts as a potential marker and suppresses tumor growth in gastric cancer. |
| Q42215399 | miR-148b inhibits glycolysis in gastric cancer through targeting SLC2A1. |
| Q37564535 | miR-26a desensitizes non-small cell lung cancer cells to tyrosine kinase inhibitors by targeting PTPN13. |
| Q36841322 | miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression |
| Q92761624 | miR-26a promotes hepatocellular carcinoma invasion and metastasis by inhibiting PTEN and inhibits cell growth by repressing EZH2 |
| Q58725258 | miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2) |
Search more.